Is a cannabis business a good investment?

What the profitability data says

Most licensed cannabis businesses do not make money. In its June 2024 survey of licensed operators, Whitney Economics found 27.3% profitable, 40.6% breaking even, and 32.2% not profitable. The same release put the comparable figure for all U.S. small businesses at 65.3%.

The trend matters as much as the level. The firm reported 42.4% of operators profitable in 2022, 24.6% in 2023, and 27.3% in 2024. The share only breaking even doubled over that period, from 20.3% to 40.6%. Its earlier survey report listed the causes operators named: falling prices against rising costs, tax and regulatory burden, and no access to normal capital.

These are self-reported survey answers, not audited results. Treat them as a base rate. If roughly one operator in four is profitable, your diligence has to show why the target is in that quarter and will stay there under your ownership.

Why is it so hard to make money in cannabis?

Four structural problems explain most of the gap between cannabis and ordinary small business.

Section 280E taxes gross profit, not net income

IRC 280E disallows deductions and credits for a business trafficking in a Schedule I or II substance. Cost of goods sold still reduces taxable income; rent, payroll, marketing, and other operating costs do not. The April 2026 federal rule moved FDA-approved products and marijuana under a state medical licence to Schedule III, so qualifying medical activity is outside 280E going forward. Adult-use marijuana is still Schedule I. Adult-use operators still pay tax this way, and dual-licence operators must apportion.

Illustrative example, adult-use retailer, 21% federal corporate rate:

Line	Ordinary business	Under 280E
Revenue	$4,000,000	$4,000,000
Cost of goods sold	$2,000,000	$2,000,000
Gross profit	$2,000,000	$2,000,000
Operating expenses	$1,400,000	$1,400,000 (not deductible)
Pre-tax income	$600,000	$600,000
Federal taxable income	$600,000	$2,000,000
Federal tax at 21%	$126,000	$420,000
Cash after federal tax	$474,000	$180,000

Same store, same sales, 62% less cash. The effective federal rate on real income is 70%. Whitney Economics cited operators facing effective rates of 52.5% in the 2024 release above. The mechanics are covered in 280E explained for buyers and sellers, and the pricing consequence in how 280E affects valuation.

Prices keep falling in open markets

Whitney Economics told Shanken News Daily in July 2026 that prices in maturing markets have been dropping 10 to 20% a year, that Arizona prices are down about 35% since adult-use sales began in 2021, and that U.S. cannabis stocks sit at roughly six times demand. The same analysis counted 24 states with declining cannabis revenue in 2025 and 15 with growth. In 2020 the split was 5 declining and 30 growing.

A buyer underwriting flat prices in an uncapped state is underwriting against the record. See how oversupply and price compression affect value for how this flows into price.

Operators are exiting

Licence counts show the attrition. Oklahoma’s regulator reports 1,735 active growers on 1 September 2026, down from a peak of 9,402 in December 2021. Dispensaries fell from 2,611 (November 2023) to 1,295, and processors from 1,805 (May 2023) to 574. Some of that is enforcement against illegal operators. Much of it is businesses that could not cover costs.

Capital is scarce and failure is messy

Marijuana businesses cannot get SBA 7(a) or 504 loans, and the SAFE Banking Act of 2026 has been introduced but not enacted. Acquisition debt, where it exists, comes from private lenders at higher rates; see cannabis acquisition financing options. Plant-touching businesses also generally cannot use federal bankruptcy, so a failed investment is resolved through state receivership or a wind-down, which recovers less for equity.

Where do returns actually exist?

Returns concentrate in a few situations. None is guaranteed, and each has its own way of going wrong.

1. Scarce-licence markets. Where the state or the city has stopped issuing licences, existing holders face fewer new competitors. Washington’s Liquor and Cannabis Board, for example, is not accepting new retailer, producer, or processor applications outside its social equity program. The trade-off is a higher entry price. The comparison is laid out in limited-licence vs open-market states.
2. Medical and dual-licence operators after the 2026 rule. A business with qualifying medical activity may now deduct ordinary expenses against that activity. The benefit depends on the medical share of sales and on how the IRS treats apportionment, so model it as a separate case, not as the base case.
3. Low-cost producers. In an oversupplied wholesale market the last survivors are the growers with the lowest cost per pound. Compare the target against the figures in cannabis benchmarks.
4. Distressed purchases. When operators exit, licences, equipment, and leases change hands below replacement cost. The price is low because the risk is real: unpaid taxes, compliance history, and deferred maintenance. Start with valuing a distressed cannabis business.
5. Well-located retail with local protection. A store inside a municipal cap or a tight zoning envelope has a moat that state law alone does not provide.

How to test whether a specific deal is a good investment

Ask five questions before you look at anything else.

Question	What a good answer looks like
What is cash flow after 280E and state excise tax?	Seller’s numbers reconcile to filed returns, and the price is based on after-tax cash, not pre-tax EBITDA
What happens if prices fall another 15%?	The business still covers debt service and rent
How many more licences can the state or city issue?	A cap, a moratorium, or a local limit you can cite
Can the licence legally move to you?	A clear change-of-ownership path and an owner group that qualifies
How will you pay for it?	Committed cash, seller note, or private credit on terms the cash flow supports

The full process is in how to evaluate a cannabis business for sale. If you would rather own the economics without the licence risk, compare plant-touching vs ancillary investment.

A realistic way to think about it

Cannabis is not a growth story you can buy at any price. It is a regulated, cash-heavy, heavily taxed consumer business where the median operator breaks even. Buyers who do well pay for demonstrated after-tax cash flow, in a market with a limit on new supply, with capital that does not force a sale at the first price dip. Everything on this page is general education, not investment, tax, or legal advice, and nothing here predicts the result of any particular purchase.